APUS · Apimeds Pharmaceuticals US, Inc. · Fails to Deliver
$1.83
+0.16 (+9.58%)
At close · Sep 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.47M
Shares
1.51M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-28 | 2,965 | $3.95 | $11,712 |
| 2026-08-27 | 1 | $4.60 | $5 |
| 2026-08-26 | 252 | $4.97 | $1,252 |
| 2026-08-25 | 251 | $4.75 | $1,192 |
| 2026-08-19 | 10,208 | $4.00 | $40,832 |
| 2026-08-18 | 13,032 | $4.28 | $55,777 |
| 2026-08-06 | 204 | $4.65 | $949 |
| 2026-08-03 | 861 | $5.15 | $4,434 |
| 2026-07-31 | 1,651 | $4.92 | $8,123 |
| 2026-07-30 | 1,088 | $5.75 | $6,256 |
| 2026-07-29 | 4,107 | $8.00 | $32,856 |
| 2026-07-28 | 393 | $6.29 | $2,472 |
| 2026-07-21 | 1,949 | $0.65 | $1,267 |
| 2026-07-20 | 314 | $0.66 | $207 |
| 2026-07-17 | 910 | $0.66 | $601 |
| 2026-07-16 | 2,926 | $0.71 | $2,077 |
| 2026-07-10 | 3,648 | $0.74 | $2,700 |
| 2026-07-09 | 6,362 | $0.74 | $4,708 |
| 2026-07-07 | 3,661 | $0.86 | $3,148 |
| 2026-07-01 | 3,074 | $0.90 | $2,767 |
| 2026-06-30 | 8,754 | $0.93 | $8,141 |
| 2026-06-18 | 297 | $1.31 | $389 |
Showing 1–22 of 22 settlements